City
Epaper

WHO experts back Covid booster dose for immunocompromised

By IANS | Updated: October 12, 2021 09:05 IST

Geneva, Oct 12 Experts from the World Health Organization (WHO) have recommended that Covid-19 booster shots should be ...

Open in App

Geneva, Oct 12 Experts from the World Health Organization (WHO) have recommended that Covid-19 booster shots should be offered to moderately and severely immunocompromised people.

After four days of talks last week, the WHO's Strategic Advisory Group of Experts on Immunization (SAGE) on Monday recommended that such people should receive a third dose of a vaccine on the WHO Emergency Use Listing (UEL) as they are "less likely to respond adequately to vaccination following a standard primary vaccine series and are at high risk of severe Covid-19 disease", reports Xinhua news agency.

Since the end of September, several Covid-19 vaccines have been certified by the WHO UEL, including Pfizer-BioNTech, Janssen, Moderna, Sinopharm, Sinovac, AstraZeneca, and Covishield.

SAGE said it had also reviewed COVAXIN, made by India's Bharat Biotech, and a policy recommendation will be issued once the vaccine is approved by the WHO UEL.

Third doses of the Chinese Sinovac and Sinopharm inactivated virus vaccines should be offered to those over 60, said WHO experts.

Meanwhile, the use of a heterologous (or live virus) jab for the additional dose may also be considered based on vaccine supply and access considerations.

"When implementing this recommendation, countries should initially aim at maximising two-dose coverage in that population, and thereafter administer the third dose, starting in the oldest age groups," SAGE said.

The WHO had earlier called for a global moratorium on Covid-19 booster doses, aiming for a more equitable distribution of vaccines globally to enable every country to vaccinate at least 40 percent of its population.

Last week, the Organization announced an initiative to vaccinate 40 per cent of the population of every country against Covid-19 by the end of 2021, and 70 per cent by mid-2022.

This drive would prioritise vaccine delivery to low-income countries, particularly those in Africa.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Who's strategic advisory groupindiaGenevaWorld Health OrganizationWhoWorld healthU of u healthFinance and healthIndiUk-indiaNational public health organization
Open in App

Related Stories

TechnologyWill the Government Have to Offer More Incentives on EVs? NITI Aayog Raises Concerns Over Slow Sales Growth

OpinionsWhy is Trump So Upset with India?

MumbaiUniversity of Bristol Chooses Mumbai for Its First Overseas Campus, Set to Open in September 2026

NationalRaksha Bandhan 2025: Now You Can Send a Rakhi to Your Brother in India Post's Waterproof Envelope — Here's How to Track Your Parcel

NationalGold in Dubai Cheaper Than India: Pricing, Rules, and Import Limits Explained

Health Realted Stories

HealthIndia’s study on nutritional impact on TB outcomes contributed to global guidance: WHO

HealthFitness Mistakes That Could Be Dangerous for Your Heart, Say Experts

HealthHow to Naturally Boost Vitamin B12 Without Supplements

HealthDrinking coffee at night may raise impulsivity in women: Study

HealthUttarkashi cloudburst: Health Dept on high alert, specialist doctors rushed for relief efforts